Cite

HARVARD Citation

    Cappuzzo, F. et al. (2016). Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer. Lung cancer. pp. 31-37. [Online]. 
  
Back to record